SELLAS Life Sciences will participate in the next conferences in October 2021

NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) – SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), an advanced-stage clinical biopharmaceutical company focused on the development of novel immunotherapies anticancer drugs for a wide range of indications, Angelos Stergiou, MD, ScD. hc, president and ceo of SELLAS, will attend two upcoming conferences:

  • The Laguna Biotech 2021 CEO Forum will be held at the Montage Laguna Beach Hotel in Laguna Beach, California, October 10-12, 2021.

  • AGP / Alliance Global Partners Biotech & Specialty Pharma conference to be held virtually on Wednesday, October 13, 2021.

For more information on conferences or to schedule a one-to-one meeting with SELLAS management, please contact your representative directly or email AGP / Alliance Global Partners at [email protected], or at KCSA Strategic Communications at SELLAS @ kcsa.com.

About SELLAS Life Sciences Group, Inc.
SELLAS is an advanced clinical biopharmaceutical company focused on the development of novel cancer immunotherapeutics for a wide range of indications. SELLAS ‘lead product candidate, galinpepimut-S (GPS), is licensed by Memorial Sloan Kettering Cancer Center and targets the WT1 protein, which is found in a variety of tumor types. GPS has potential both as monotherapy and in combination to treat a wide range of hematologic malignancies and solid tumor indications. SELLAS ‘second product candidate, nelipepimut-S (NPS), is a cancer immunotherapy directed against HER2 that can treat patients with early-stage breast cancer with low to intermediate HER2 expression, also known as the name HER2 1+ or 2+, which includes patients with triple negative breast cancer (TNBC), depending on the standard of care.

For more information on SELLAS, please visit www.sellaslifesciences.com.

Investor contacts
Allison soss
KCSA strategic communication
212,896,1267
[email protected]

Media contacts
Raquel cona
KCSA strategic communication
212.896.1204
[email protected]

About Stephen Arrington

Check Also

MDI Biology Laboratory Hosts First African Turquoise Killifish Conference

The biennial event will serve as a focal point for the research community in the …

Leave a Reply

Your email address will not be published. Required fields are marked *